Search results
California Partners with New Jersey Firm to Buy Generic Opioid Overdose Reversal Drug | KQED
KQED· 14 hours agoThe naloxone packs purchased by California initially will be available under the Amneal label. The...
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)
KOLR - KSFX Ozarks· 5 hours agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Proactive Investors· 4 days agoHemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO ...Proactive's Stephen Gunnion that 2023 was...
Dean Farmer, PhD
The National Law Review· 13 hours agoDean is a leading patent strategist in the life sciences sector who works with biotechnology and pharmaceutical companies at all stages of development. Dean handles patent ...
US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
Reuters via Yahoo News· 22 hours ago(Reuters) -X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare...
General Inception Launches Igniter Europe with the support of leading institutions and venture...
PRWeb· 6 hours agoPALO ALTO, Calif. and LYON, France, April 29, 2024 /PRNewswire-PRWeb/ -- General Inception announces the launch of Igniter Europe, focused on building innovative companies in the field of oncology ...
Rebounding R&D returns spell success for local pharmaceutical companies, report shows
Crain's New York Business· 4 days agoWhile 2022’s record-low returns didn’t necessarily spell trouble for firms in New York and New Jersey, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, said the report’s results ...
FDA grants full approval to cervical cancer drug TIVDAK By Investing.com
Investing.com· 9 hours ago(NYSE: NYSE:PFE) and Genmab A/S (NASDAQ: NASDAQ:GMAB) have received full approval from the U.S. Food...
Foresee Pharmaceuticals Announces Poster Presentation and Participation at the 2024 American...
WTNH-TV New Haven· 1 day agoForesee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today that it will actively participate...
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
Pharmaceutical Technology via Yahoo Finance· 18 hours agoApproximately 25% of all disclosed deals involved US, Canadian, and European headquartered clients....
